Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-27 4:15 pm Purchase | 2025-01-22 | 13G | Hepion Pharmaceuticals, Inc. HEPA | S.H.N. Financial Investments Ltd. | 1,060,883 9.990% | 1,060,883 (New Position) | Filing History |
| 2025-01-24 8:32 pm Purchase | 2025-01-21 | 13G | Hepion Pharmaceuticals, Inc. HEPA | BIGGER CAPITAL FUND L P | 1,060,883 9.990% | 1,060,883 (New Position) | Filing History |
| 2024-11-14 4:07 pm Sale | 2024-09-30 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Armistice Capital, LLC | 304,574 4.990% | -113,426 (-27.14%) | Filing History |
| 2024-02-14 3:38 pm Purchase | 2023-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Armistice Capital, LLC | 418,000 8.670% | 418,000 (New Position) | Filing History |
| 2022-02-14 06:05 am Sale | 2021-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Altium Capital Management LLC | 0 0.000% | -225,000 (Position Closed) | Filing History |
| 2022-02-10 08:17 am Purchase | 2021-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | VANGUARD GROUP INC | 166,301 4.360% | 79,871 (+92.41%) | Filing History |
| 2022-01-19 10:48 am Sale | 2021-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Empery Asset Management LP | 16,787 0.440% | -183,213 (-91.61%) | Filing History |
| 2022-01-03 5:57 pm Sale | 2021-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | SABBY MANAGEMENT LLC | 30,191 11.000% | -219,809 (-87.92%) | Filing History |
| 2021-02-24 10:46 am Purchase | 2021-02-16 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Altium Capital Management LLC | 225,000 5.900% | 225,000 (New Position) | Filing History |
| 2021-02-19 2:45 pm Purchase | 2021-02-16 | 13G | Hepion Pharmaceuticals, Inc. HEPA | SABBY MANAGEMENT LLC | 250,000 11.000% | 220,833 (+757.14%) | Filing History |
| 2021-02-18 10:49 am Purchase | 2021-02-16 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Empery Asset Management LP | 200,000 5.250% | 183,213 (+1091.38%) | Filing History |
| 2021-02-16 09:59 am Purchase | 2020-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | CVI Investments, Inc. | 21,000 1.300% | 11,823 (+128.84%) | Filing History |
| 2021-02-10 10:57 am Purchase | 2020-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | VANGUARD GROUP INC | 86,430 5.960% | 86,430 (New Position) | Filing History |
| 2021-02-09 3:50 pm Purchase | 2020-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Hudson Bay Capital Management LP | 14,794 0.920% | 112 (+0.76%) | Filing History |
| 2021-01-20 11:10 am Sale | 2020-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Empery Asset Management LP | 16,787 1.050% | -83,213 (-83.21%) | Filing History |
| 2021-01-07 1:38 pm Sale | 2020-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | SABBY MANAGEMENT LLC | 29,167 11.000% | -70,854 (-70.84%) | Filing History |
| 2020-12-28 4:57 pm Sale | 2020-12-23 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Orin Hirschman | 58,662 4.000% | -41,339 (-41.34%) | Filing History |
| 2020-12-09 06:49 am Purchase | 2020-11-25 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Orin Hirschman | 100,000 6.900% | 100,000 (New Position) | Filing History |
| 2020-12-02 11:12 am Purchase | 2020-11-25 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Empery Asset Management LP | 100,000 6.910% | 100,000 (New Position) | Filing History |
| 2020-12-01 8:48 pm Purchase | 2020-11-25 | 13G | Hepion Pharmaceuticals, Inc. HEPA | SABBY MANAGEMENT LLC | 100,021 11.000% | 100,021 (New Position) | Filing History |